ETON vs NBHC
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ETON · Eton Pharmaceutical$56.46 ▲ 19.75%
NBHC · National Bank$36.91 ▼ 0.86%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ETON +233.7%
- NBHC +2.5%
Head to head
| Metric | ETON | NBHC |
|---|---|---|
| Price | $56.46 | $36.91 |
| Change today | ▲ 19.75% | ▼ 0.86% |
| Market cap | $1.63B | $1.63B |
| Return, 3 months | +29.3% | -13.3% |
| Return, year to date | +233.9% | -0.6% |
| Return, 1 year | +234.1% | +4.8% |
| P/E (TTM) | 36.7 | 29.3 |
| P/B | 18.7 | 1.0 |
| P/E percentile vs own 5y | 97th | 100th |
| Dividend yield | – | 3.44% |
| Revenue growth (YoY, latest qtr) | +98.6% | +19.3% |
| Net profit growth (YoY) | +547.9% | -124.8% |
| Gross margin | 57.9% | – |
| Operating margin | 15.4% | – |
| Net margin | 12.0% | 11.2% |
| Return on equity | 36.0% | 3.6% |
| Analyst target vs. price | +26.3% | +20.6% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 59 | 38 |
| 30-day volatility | 77.8% | 23.2% |
| Max drawdown, 1 year | -26.8% | -21.0% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NBHC is the largest of the group by market value.
- ETON has returned the most over the past year.
- NBHC carries the lowest trailing P/E.
- ETON is growing revenue fastest.
- ETON keeps the most profit per dollar of sales.
- NBHC has been the calmest stock over the last 30 days.